Financial Performance - The company's operating revenue for Q1 2025 was ¥1,083,171,677.45, a decrease of 22.19% compared to the same period last year[4]. - The net profit attributable to shareholders was a loss of ¥8,556,904.43, an improvement of 59.00% from a loss of ¥20,871,739.14 in the previous year[4]. - Basic and diluted earnings per share were both -¥0.0145, showing a 59.04% improvement from -¥0.0354 in the previous year[4]. - The company's net profit margin was impacted by a significant increase in financial expenses, which rose to ¥22,886,756.40 from ¥10,384,913.00, reflecting a 120% increase[20]. - The net profit for the current period is -13,440,239.56, an improvement from -20,716,801.32 in the previous period, representing a decrease in net loss of approximately 35%[21]. - The total comprehensive income for the current period is 29,363,025.88, compared to -50,418,878.54 in the previous period, indicating a significant recovery[21]. - The total operating profit for the current period is -24,633,247.88, an improvement from -26,895,103.40 in the previous period, showing a reduction in operating losses[21]. Cash Flow - The net cash flow from operating activities improved by 67.85%, amounting to a net outflow of ¥147,730,837.30, compared to a net outflow of ¥459,497,946.67 in the same period last year[4]. - Cash flow from operating activities shows a net outflow of -147,730,837.30, an improvement from -459,497,946.67 in the previous period[23]. - Cash flow from investing activities has a net outflow of -119,669,546.19, compared to -868,984,903.03 in the previous period, indicating reduced investment losses[23]. - Cash flow from financing activities shows a net inflow of 109,815,057.03, a decrease from 1,102,167,793.19 in the previous period, reflecting a reduction in financing activities[24]. Assets and Liabilities - Total assets at the end of the reporting period were ¥13,204,719,138.23, a decrease of 0.80% from the end of the previous year[4]. - Current liabilities totaled ¥7,182,337,198.32, down from ¥7,347,852,543.54, indicating a reduction of approximately 2.3%[19]. - The company's cash and cash equivalents decreased to ¥1,149,546,287.64 from ¥1,278,390,795.81, a decline of 10.1%[18]. - The cash and cash equivalents at the end of the period amount to 810,399,084.13, compared to 279,193,839.84 at the end of the previous period, showing an increase in liquidity[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 26,863[12]. - The largest shareholder, Changsha Chutian Investment Group, holds 38.07% of shares, totaling 224,706,614 shares[12]. - Hunan Caixin Jingxin Investment Partnership holds 2.68% of shares, totaling 15,816,000 shares[12]. - Liu Yan, an individual shareholder, holds 1.99% of shares, totaling 11,722,250 shares[12]. - The top 10 shareholders account for a significant portion of the company's equity, with the largest shareholder alone holding over 38%[12]. - The company has no preferred shareholders as indicated in the report[14]. - There are no changes in the number of restricted shares for key executives during the reporting period[15]. - The total number of restricted shares at the end of the period is 14,118,283 shares[15]. - The report indicates that key executives have locked shares that can be released gradually over their tenure[15]. - The company has not engaged in any share lending or borrowing activities during the reporting period[12]. Cost Management - Research and development expenses decreased by 34.14%, amounting to a reduction of ¥49,391,500 compared to the previous year[9]. - The company implemented cost reduction and efficiency enhancement measures, resulting in a 16.86% decrease in period expenses compared to the previous year[8]. Investment and Financing - Investment income increased by 424.89%, amounting to an increase of ¥1,430,200 compared to the previous year due to higher returns from bank wealth management products[9]. - The company reported a significant decrease in financing cash flow, down 90.04% to a net outflow of ¥99,235,270, primarily due to the absence of convertible bond issuance in the current period[10]. Revenue and Sales - The report indicates that sales revenue from goods and services was 1,404,767,950.05, down from 1,743,978,201.95 in the previous period, indicating a decline of approximately 19%[23]. - Total operating revenue for the current period was ¥1,083,171,677.45, a decrease of 22.2% compared to ¥1,392,029,678.89 in the previous period[20]. - Total operating costs amounted to ¥1,123,822,892.53, down 22.1% from ¥1,443,898,305.35 in the previous period[20]. Project Updates - The company has extended the timeline for the "Medical Equipment and Materials Technology Research Center Project" to March 2026, reflecting a cautious approach to current industry conditions[17]. - The board decided not to adjust the conversion price of the "Chutian Convertible Bonds" downward, maintaining the current terms for the next three months[16].
楚天科技(300358) - 2025 Q1 - 季度财报